State of play of pharmacogenetics and personalized medicine in heart failure

Helen M. Parry (Lead / Corresponding author), Alexander Doney, Colin N. A. Palmer, Chim C. Lang

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)

    Abstract

    Heart failure is a common disease with high levels of morbidity and mortality. A large body of evidence guiding treatment shows prognostic benefit with beta blockers and ACE inhibitors, while diuretics are commonly prescribed for symptomatic benefit. Wide variation in drug response between clinically similar patients is a significant problem. Evidence suggests this may have a genetic component. © 2013 Blackwell Publishing Ltd.
    Original languageEnglish
    Pages (from-to)315-322
    Number of pages8
    JournalCardiovascular Therapeutics
    Volume31
    Issue number6
    DOIs
    Publication statusPublished - 2013

    Fingerprint Dive into the research topics of 'State of play of pharmacogenetics and personalized medicine in heart failure'. Together they form a unique fingerprint.

    Cite this